These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

220 related articles for article (PubMed ID: 26139080)

  • 1. The role of GRIK4 gene in treatment-resistant depression.
    Milanesi E; Bonvicini C; Congiu C; Bortolomasi M; Gainelli G; Gennarelli M; Minelli A
    Genet Res (Camb); 2015 Jul; 97():e14. PubMed ID: 26139080
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Influence of GRIK4 genetic variants on the electroconvulsive therapy response.
    Minelli A; Congiu C; Ventriglia M; Bortolomasi M; Bonvicini C; Abate M; Sartori R; Gainelli G; Gennarelli M
    Neurosci Lett; 2016 Jul; 626():94-8. PubMed ID: 27222927
    [TBL] [Abstract][Full Text] [Related]  

  • 3. The role of the potassium channel gene KCNK2 in major depressive disorder.
    Congiu C; Minelli A; Bonvicini C; Bortolomasi M; Sartori R; Maj C; Scassellati C; Maina G; Trabucchi L; Segala M; Gennarelli M
    Psychiatry Res; 2015 Feb; 225(3):489-92. PubMed ID: 25535009
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Influence of BCL2 gene in major depression susceptibility and antidepressant treatment outcome.
    Zhang C; Wu Z; Hong W; Wang Z; Peng D; Chen J; Yuan C; Yu S; Xu L; Fang Y
    J Affect Disord; 2014 Feb; 155():288-94. PubMed ID: 24321200
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Common variants in GRIK4 and major depressive disorder: An association study in the Chinese Han population.
    Ren D; Bi Y; Xu F; Niu W; Zhang R; Hu J; Guo Z; Wu X; Cao Y; Huang X; Yang F; Wang L; Li W; Xu Y; He L; Yu T; He G; Li X
    Neurosci Lett; 2017 Jul; 653():239-243. PubMed ID: 28583584
    [TBL] [Abstract][Full Text] [Related]  

  • 6. GRIK4 polymorphism and its association with antidepressant response in depressed patients: a meta-analysis.
    Kawaguchi DM; Glatt SJ
    Pharmacogenomics; 2014 Aug; 15(11):1451-9. PubMed ID: 25303296
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Failure to replicate influence of GRIK4 and GNB3 polymorphisms on treatment outcome in major depression.
    Serretti A; Chiesa A; Crisafulli C; Massat I; Linotte S; Calati R; Kasper S; Bailer U; Lecrubier Y; Fink M; Antonijevic I; Forray C; Snyder L; Bollen J; Zohar J; De Ronchi D; Souery D; Mendlewicz J
    Neuropsychobiology; 2012; 65(2):70-5. PubMed ID: 22222462
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A study of N-methyl-D-aspartate receptor gene (GRIN2B) variants as predictors of treatment-resistant major depression.
    Zhang C; Li Z; Wu Z; Chen J; Wang Z; Peng D; Hong W; Yuan C; Wang Z; Yu S; Xu Y; Xu L; Xiao Z; Fang Y
    Psychopharmacology (Berl); 2014 Feb; 231(4):685-93. PubMed ID: 24114429
    [TBL] [Abstract][Full Text] [Related]  

  • 9. FAS -670A>G genetic polymorphism Is associated with Treatment Resistant Depression.
    Santos M; Carvalho S; Lima L; Mota-Pereira J; Pimentel P; Maia D; Correia D; Gomes S; Cruz A; Medeiros R
    J Affect Disord; 2015 Oct; 185():164-9. PubMed ID: 26186532
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Higher polygenic risk scores for schizophrenia may be suggestive of treatment non-response in major depressive disorder.
    Fanelli G; Benedetti F; Kasper S; Zohar J; Souery D; Montgomery S; Albani D; Forloni G; Ferentinos P; Rujescu D; Mendlewicz J; Serretti A; Fabbri C
    Prog Neuropsychopharmacol Biol Psychiatry; 2021 Jun; 108():110170. PubMed ID: 33181205
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Pleiotropic genes in psychiatry: Calcium channels and the stress-related FKBP5 gene in antidepressant resistance.
    Fabbri C; Corponi F; Albani D; Raimondi I; Forloni G; Schruers K; Kasper S; Kautzky A; Zohar J; Souery D; Montgomery S; Cristalli CP; Mantovani V; Mendlewicz J; Serretti A
    Prog Neuropsychopharmacol Biol Psychiatry; 2018 Feb; 81():203-210. PubMed ID: 28989100
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Polygenic risk scores of lithium response and treatment resistance in major depressive disorder.
    Xiong Y; Karlsson R; Song J; Kowalec K; Rück C; Sigström R; Jonsson L; Clements CC; Andersson E; Boberg J; Lewis CM; Sullivan PF; Landén M; Lu Y
    Transl Psychiatry; 2023 Sep; 13(1):301. PubMed ID: 37770441
    [TBL] [Abstract][Full Text] [Related]  

  • 13. A clinical approach to treatment resistance in depressed patients: What to do when the usual treatments don't work well enough?
    Dodd S; Bauer M; Carvalho AF; Eyre H; Fava M; Kasper S; Kennedy SH; Khoo JP; Lopez Jaramillo C; Malhi GS; McIntyre RS; Mitchell PB; Castro AMP; Ratheesh A; Severus E; Suppes T; Trivedi MH; Thase ME; Yatham LN; Young AH; Berk M
    World J Biol Psychiatry; 2021 Sep; 22(7):483-494. PubMed ID: 33289425
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Association of GRIK4 with outcome of antidepressant treatment in the STAR*D cohort.
    Paddock S; Laje G; Charney D; Rush AJ; Wilson AF; Sorant AJ; Lipsky R; Wisniewski SR; Manji H; McMahon FJ
    Am J Psychiatry; 2007 Aug; 164(8):1181-8. PubMed ID: 17671280
    [TBL] [Abstract][Full Text] [Related]  

  • 15. GRIK4 and GRM7 gene may be potential indicator of venlafaxine treatment reponses in Chinese of Han ethnicity.
    Sun Q; Yuan F; Yuan R; Ren D; Zhu Y; Bi Y; Hu J; Guo Z; Xu F; Niu W; Ma G; Wu X; Yang F; Wang L; Li X; Yu T; He L; He G
    Medicine (Baltimore); 2019 May; 98(19):e15456. PubMed ID: 31083176
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Polymorphisms in GRIK4, HTR2A, and FKBP5 show interactive effects in predicting remission to antidepressant treatment.
    Horstmann S; Lucae S; Menke A; Hennings JM; Ising M; Roeske D; Müller-Myhsok B; Holsboer F; Binder EB
    Neuropsychopharmacology; 2010 Feb; 35(3):727-40. PubMed ID: 19924111
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Patterns of response to antidepressants in major depressive disorder: Drug resistance or worsening of depression are associated with a bipolar diathesis.
    Perugi G; Pacchiarotti I; Mainardi C; Verdolini N; Menculini G; Barbuti M; Angst J; Azorin JM; Bowden CL; Mosolov S; Young AH; Vieta E;
    Eur Neuropsychopharmacol; 2019 Jul; 29(7):825-834. PubMed ID: 31227264
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Characterization of treatment resistant depression episodes in a cohort of patients from a US commercial claims database.
    Kubitz N; Mehra M; Potluri RC; Garg N; Cossrow N
    PLoS One; 2013; 8(10):e76882. PubMed ID: 24204694
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Treatment-resistant depression as risk factor for substance use disorders-a nation-wide register-based cohort study.
    Brenner P; Brandt L; Li G; DiBernardo A; Bodén R; Reutfors J
    Addiction; 2019 Jul; 114(7):1274-1282. PubMed ID: 30938020
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Association of the TLR4 gene with depressive symptoms and antidepressant efficacy in major depressive disorder.
    Wang J; Yang C; Liu Z; Li X; Liu M; Wang Y; Zhang K; Sun N
    Neurosci Lett; 2020 Sep; 736():135292. PubMed ID: 32763359
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.